SubscribeLogin
Published

Attention turns to multi-organ denervation as new evidence supports “durability” of blood pressure reductions - Cardiovascular News

Summary by Cardiovascular News
David Kandzari New research will investigate the safety and efficacy of multi-organ, hepatic artery and renal artery denervation using the Symplicty Spyral (Medtronic) catheter in uncontrolled hypertension patients who are both on and off medications. A planned global pilot study, SPYRAL GEMINI, represents the latest frontier in sympathetic denervation research, following the US Food and Drug Administration (FDA) approval of the Symplicity Spyra…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Atlanta, GeorgiaAtlanta, Georgia
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal